METHUSELAH ARCHIVE INTERVENTIONS / MARINE PLASMA (SÉRUM DE QUINTON)

Marine plasma (Sérum de Quinton)

injection · 1897–1925
category:injection
delivery:Subcutaneous or intravenous injection of filtered, cold-sterilized Atlantic seawater diluted to isotonic concentration (~9 g/L dissolved solids). From 1906 administered at marine dispensaries; also sold commercially as a drinkable preparation and later as topical sprays.
price tier:mass
era:1897–1925
current status:both
regulatory:supplement
SHORT PITCH (AS SOLD)
Diluted, microfiltered Atlantic seawater maintains the 'original marine milieu' of animal cells; injected isotonically, it can replace blood plasma, reverse fatal dehydration, and cure diseases of wasting and malnutrition.
THE ACTUAL EVIDENCE
No randomized controlled trials of marine plasma therapy exist. Case reports and practitioner accounts from the 1906–1925 dispensary era were published without control groups or blinded outcome assessment. The 1913 American review by Stevens reports Quinton's clinical claims in a favorable register but contains no independent outcome verification. The French AMM for Quinton plasma preparations (Plasma de Quinton and Duplase de Quinton, registered 1943) was revoked in 1993 under modern EU regulatory standards, indicating the evidence base was insufficient by those criteria. The preparations are not listed in current physicians' references (Vidal). The current commercial Quinton products (quinton.bio, quintonmedical.com) are marketed as health and hygiene supplements, not as licensed pharmaceutical drugs.
PRACTITIONERS
INGREDIENTS
CASES
CLAIMS
SOURCES
  1. L'eau de mer, milieu organique (2nd ed., 1912) (1912)
  2. Isotonic Sea Water in Therapeutics (1913)
  3. Laboratory History (quinton.bio) (2026)
  4. René Quinton biography (quinton.bio) (2026)
  5. René Quinton (Wikipedia) (2026)
NOTES

Marine plasma, also called sérum de Quinton or Plasma de Quinton, is the preparation of Atlantic seawater collected from selected offshore deep-water zones, cold-filtered to remove microorganisms, and diluted with distilled water to approximately isotonic concentration (~9 g/L). René Quinton developed and commercialized the preparation from 1905, patented it in 1907, and administered it at free marine dispensaries beginning in 1906. The preparation was theoretically grounded in Quinton’s Law of Marine Constancy, which held that all animal cells retain an internal milieu identical in mineral composition to primordial seawater.

The intervention sits at the boundary between a genuinely functional rehydration agent and an elaborate theoretical superstructure that the underlying chemistry does not support. Isotonic fluid replacement does prevent death from dehydration; whether filtered seawater provides any additional benefit over pharmaceutical saline has not been established in controlled trials. The marine plasma dispensaries operated in an era before randomized trial methodology, when case-report observation was the primary evidence standard.

Laboratoires Quinton International S.L. (quinton.bio, quintonmedical.com), based in Alicante, Spain, currently markets seawater-based products including Quinton Medical, Quinton Sport, Eau de Quinton, and various spray formulations. The company states that its products follow Quinton’s original collection and cold-filtration protocols and are marketed as health and hygiene products rather than licensed pharmaceutical drugs. The company characterizes its products as “marine therapy” and maintains a website at quinton.bio.